Published on 5 Apr 2024 on Zacks via Yahoo Finance

CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $65.06, moving +0.71% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 1.23% for the day. Elsewhere, the Dow lost 1.36%, while the tech-heavy Nasdaq lost 1.4%.

Heading into today, shares of the company had lost 20.08% over the past month, lagging the Medical sector's loss of 1.23% and the S&P 500's gain of 1.61% in that time.

The upcoming earnings release of CRISPR Therapeutics AG will be of great interest to investors. In that report, analysts expect CRISPR Therapeutics AG to post earnings of -$1.63 per share. This would mark a year-over-year decline of 143.28%. At the same time, our most recent consensus estimate is projecting a revenue of $8.31 million, reflecting a 91.69% fall from the equivalent quarter last year.